https://ticagrelorantagonist.c....om/cerebrovascular-a
OUTCOMES 513 PLHIV had been enrolled. The most frequent antiretroviral regimens had been TDF+3TC+EFV (269) and AZT+3TC+EFV (155). 53 (10.3%) subjects failed treatment. Among these, 48 (90.6%) had DRMs, 84.9percent were subtype CRF01_AE. Tenofovir-based regimens carried out worse than zidovudine-based regimens (OR 3.28, 95% CI 1.58 to 7.52 p less then 0.001). Greater rates of NRTI, NNRTI, K65R tenofovir opposition, and multi-class resistance were found compared to those reported in lite
Like
Comment
Share
